inclusion criteria: 1. adults ≥ 18 years 2. negative results of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) quantitative reverse transcriptase polymerase chain reaction (qrt-pcr) 3. healthy or medically stable participants 4. contraceptive within 365 days post dosing

inclusion criteria: 1. adults ≥ 18 years 2. negative results of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) quantitative reverse transcriptase polymerase chain reaction (qrt-pcr) 3. healthy or medically stable participants 4. contraceptive within 365 days post dosing

inclusion criteria: adults ≥ 18 years negative results of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) quantitative reverse transcriptase polymerase chain reaction (qrt-pcr) healthy or medically stable participants contraceptive within 365 days post dosing

inclusion criteria: adults ≥ 18 years negative results of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) quantitative reverse transcriptase polymerase chain reaction (qrt-pcr) healthy or medically stable participants contraceptive within 365 days post dosing